1. Home
  2. LGCB vs QTTB Comparison

LGCB vs QTTB Comparison

Compare LGCB & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGCB
  • QTTB
  • Stock Information
  • Founded
  • LGCB 2011
  • QTTB 2015
  • Country
  • LGCB Japan
  • QTTB United States
  • Employees
  • LGCB N/A
  • QTTB N/A
  • Industry
  • LGCB
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGCB
  • QTTB Health Care
  • Exchange
  • LGCB Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • LGCB 19.2M
  • QTTB 18.9M
  • IPO Year
  • LGCB 2023
  • QTTB N/A
  • Fundamental
  • Price
  • LGCB $2.54
  • QTTB $2.00
  • Analyst Decision
  • LGCB
  • QTTB Hold
  • Analyst Count
  • LGCB 0
  • QTTB 8
  • Target Price
  • LGCB N/A
  • QTTB $24.00
  • AVG Volume (30 Days)
  • LGCB 7.2K
  • QTTB 3.8M
  • Earning Date
  • LGCB 07-03-2025
  • QTTB 08-11-2025
  • Dividend Yield
  • LGCB N/A
  • QTTB N/A
  • EPS Growth
  • LGCB N/A
  • QTTB N/A
  • EPS
  • LGCB N/A
  • QTTB N/A
  • Revenue
  • LGCB $8,993,265.00
  • QTTB N/A
  • Revenue This Year
  • LGCB N/A
  • QTTB N/A
  • Revenue Next Year
  • LGCB N/A
  • QTTB N/A
  • P/E Ratio
  • LGCB N/A
  • QTTB N/A
  • Revenue Growth
  • LGCB 5.80
  • QTTB N/A
  • 52 Week Low
  • LGCB $1.22
  • QTTB $1.35
  • 52 Week High
  • LGCB $30.65
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • LGCB 51.21
  • QTTB 48.73
  • Support Level
  • LGCB $2.63
  • QTTB $2.02
  • Resistance Level
  • LGCB $2.77
  • QTTB $2.33
  • Average True Range (ATR)
  • LGCB 0.08
  • QTTB 0.29
  • MACD
  • LGCB -0.00
  • QTTB -0.04
  • Stochastic Oscillator
  • LGCB 51.06
  • QTTB 13.51

About LGCB Linkage Global Inc

Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The Company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: